HDM1002
A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.
Huadong Medicine · Phase 1 · Status n/r · Enrollment 30
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.